Hyperbaric oxygen therapy alleviates acute carbon monoxide poisoning-induced transition of cardiac fibroblast to myofibroblast and ameliorates cardiac fibrosis via the NRF2/ROS/TGFβ1/Smad pathway
European Journal of Pharmacology · 2026-06 · 1028 · 178992
DOI: 10.1016/j.ejphar.2026.178992 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026-06. Verfasst von Jianfei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Occupational Health (Anhui No.2 Provincial People's Hospital), Hefei City, China; Department of Cardiology, Anhui No…. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Fibroblasts, Myofibroblasts, Carbon Monoxide Poisoning. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Acute carbon monoxide poisoning (ACOP) is one of the leading causes of poisoning-related deaths worldwide, inducing severe complications such as myocardial fibrosis and cardiac dysfunction. Hyperbaric oxygen (HBO) therapy is an effective clinical treatment for carbon monoxide (CO) poisoning, but its underlying mechanisms require further investigation. METHODS An ACOP mouse model was established and treated with HBO. Carboxyhemoglobin (COHb) levels were measured, and myocardial histopathological changes and collagen deposition were determined via hematoxylin-eosin staining, Masson's trichrome staining, and immunohistochemical staining. An ACOP cell model was constructed in the human cardiac fibroblast line HCF. Cell proliferation and migration were tested in CCK-8 and Transwell assays. The DHE fluorescent probe was applied in the determination of intracellular reactive oxygen species (ROS) levels. Alpha-Smooth Muscle Actin (α-SMA) expression was examined by immunofluorescence. Finally, qRT-PCR and Western blot were used to measure the expression of fibrosis markers and proteins related to the Nuclear Factor Erythroid 2-Related Factor 2 (NRF2)/Transforming Growth Factor Beta 1 (TGF-β1)/Mothers Against Decapentaplegic Homolog (Smad) pathway. RESULTS HBO therapy significantly reduced COHb levels, improved myocardial histopathological changes and collagen deposition, repressed cell proliferation and migration, and alleviated oxidative stress. Mechanistically, HBO therapy activated the NRF2 signaling pathway, reduced ROS levels, and suppressed the TGF-β1/Smad signaling pathway, thus mitigating the transition of cardiac fibroblasts to myofibroblasts. CONCLUSION HBO therapy effectively represses ACOP-induced cardiac fibroblast-to-myofibroblast transition and ameliorates cardiac fibrosis by modulating the NRF2/ROS/TGF-β1/Smad signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Province Key Laboratory of Occupational Health (Anhui No.2 Provincial People's Hospital), Hefei City, China; Department of Cardiology, Anhui No.2 Provincial People's Hospital, Hefei City, China; Graduate School of…
- Department of Cardiology, Anhui No.2 Provincial People's Hospital, Hefei City, China.
- Department of Cardiology, Anhui No.2 Provincial People's Hospital, Hefei City, China; Graduate School of Bengbu Medical University, Bengbu City, China.
- Department of Cardiology, Anhui No.2 Provincial People's Hospital, Hefei City, China; Anhui University of Science and Technology, Huainan City, China.
- Anhui Province Key Laboratory of Occupational Health (Anhui No.2 Provincial People's Hospital), Hefei City, China. Electronic address: 1143972286@qq.com.
Zitieren
APA
Wang, J., Shi, B., Hao, Y., Chai, L., Chen, M., & Zhang, J. (2026). Hyperbaric oxygen therapy alleviates acute carbon monoxide poisoning-induced transition of cardiac fibroblast to myofibroblast and ameliorates cardiac fibrosis via the NRF2/ROS/TGFβ1/Smad pathway. European Journal of Pharmacology, 1028, 178992. https://doi.org/10.1016/j.ejphar.2026.178992
Vancouver
Wang J, Shi B, Hao Y, Chai L, Chen M, Zhang J. Hyperbaric oxygen therapy alleviates acute carbon monoxide poisoning-induced transition of cardiac fibroblast to myofibroblast and ameliorates cardiac fibrosis via the NRF2/ROS/TGFβ1/Smad pathway. European Journal of Pharmacology. 2026;1028:178992. doi:10.1016/j.ejphar.2026.178992
BibTeX
@article{Wang2026,
author = {Wang, Jianfei and Shi, Binhao and Hao, Yancheng and Chai, Lin and Chen, Mengru and Zhang, Jing},
title = {Hyperbaric oxygen therapy alleviates acute carbon monoxide poisoning-induced transition of cardiac fibroblast to myofibroblast and ameliorates cardiac fibrosis via the NRF2/ROS/TGFβ1/Smad pathway},
journal = {European Journal of Pharmacology},
year = {2026},
volume = {1028},
pages = {178992},
doi = {10.1016/j.ejphar.2026.178992}
}
EUVIMED